<VariationArchive VariationID="1074635" VariationName="NM_000206.3(IL2RG):c.148del (p.Leu50fs)" VariationType="Deletion" Accession="VCV001074635" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1065493" VariationID="1074635">
      <GeneList>
        <Gene Symbol="IL2RG" FullName="interleukin 2 receptor subunit gamma" GeneID="3561" HGNC_ID="HGNC:6010" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="71107404" stop="71111577" display_start="71107404" display_stop="71111577" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="70327253" stop="70331480" display_start="70327253" display_stop="70331480" Strand="-" />
          </Location>
          <OMIM>308380</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000206.3(IL2RG):c.148del (p.Leu50fs)</Name>
      <CanonicalSPDI>NC_000023.11:71111017:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="71111018" stop="71111018" display_start="71111018" display_stop="71111018" variantLength="1" positionVCF="71111017" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="70330868" stop="70330868" display_start="70330868" display_stop="70330868" variantLength="1" positionVCF="70330867" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L50fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.70330870del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.70330870del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.71111020del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.71111020del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009088.1" sequenceAccession="NG_009088" sequenceVersion="1" change="g.5536del">
            <Expression>NG_009088.1:g.5536del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021141.1" sequenceAccession="NG_021141" sequenceVersion="1" change="g.771del">
            <Expression>NG_021141.1:g.771del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000206.3" sequenceAccession="NM_000206" sequenceVersion="3" change="c.148del" MANESelect="true">
            <Expression>NM_000206.3:c.148del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000197.1" sequenceAccession="NP_000197" sequenceVersion="1" change="p.Leu50fs">
            <Expression>NP_000197.1:p.Leu50fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_150" sequenceAccession="LRG_150">
            <Expression>LRG_150:g.5536del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147751090" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000206.3(IL2RG):c.148del (p.Leu50fs) AND X-linked severe combined immunodeficiency" Accession="RCV001387994" Version="4">
        <ClassifiedConditionList TraitSetID="2831">
          <ClassifiedCondition DB="MedGen" ID="C1279481">X-linked severe combined immunodeficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10794430</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9058718</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2831" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 4</ElementValue>
                <XRef Type="MIM" ID="300400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">T-B+ severe combined immunodeficiency due to gamma chain deficiency</ElementValue>
                <XRef ID="MONDO:0010315" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked severe combined immunodeficiency</ElementValue>
                <XRef ID="Severe+combined+immunodeficiency%2C+x-linked/6526" DB="Genetic Alliance" />
                <XRef ID="203592006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency, X-linked, T cell-negative, B cell-positive, NK cell-negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Combined Immunodeficiency Diseases</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCIDX1</ElementValue>
                <XRef Type="MIM" ID="300400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XSCID</ElementValue>
                <XRef Type="MIM" ID="300400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD4</ElementValue>
                <XRef Type="MIM" ID="300400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SCIDX</ElementValue>
                <XRef Type="MIM" ID="300400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5618" />
                <XRef ID="5618" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of X-linked severe combined immunodeficiency (X-SCID) ranges from typical X-SCID (early-onset disease in males that is fatal if not treated with hematopoietic stem cell transplantation [HSCT] or gene therapy) to atypical X-SCID (later-onset disease comprising phenotypes caused by variable immunodeficiency, immune dysregulation, and/or autoimmunity). Typical X-SCID. Prior to universal newborn screening (NBS) for SCID most males with typical X-SCID came to medical attention between ages three and six months because of recurrent infections, persistent infections, and infections with opportunistic organisms. With universal NBS for SCID, the common presentation for typical X-SCID is now an asymptomatic, healthy-appearing male infant. Atypical X-SCID, which usually is not detected by NBS, can manifest in the first years of life or later with one of the following: recurrent upper and lower respiratory tract infections with bronchiectasis; Omenn syndrome, a clinical phenotype caused by immune dysregulation; X-SCID combined immunodeficiency (often with recurrent infections, warts, and dermatitis); immune dysregulation and autoimmunity; or Epstein-Barr virus-related lymphoproliferative complications.</Attribute>
                <XRef ID="NBK1410" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000332461" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520012" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552414" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000334606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522347" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555662" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301584</ID>
                <ID Source="BookShelf">NBK1410</ID>
              </Citation>
              <XRef ID="276" DB="Orphanet" />
              <XRef ID="C1279481" DB="MedGen" />
              <XRef ID="MONDO:0010315" DB="MONDO" />
              <XRef Type="MIM" ID="300400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3114437" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11582646|MedGen:C1279481" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588776" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9058718</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10794430</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu50Serfs*21) in the IL2RG gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with IL2RG-related conditions. Loss-of-function variants in IL2RG are known to be pathogenic (PMID: 9058718, 10794430). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IL2RG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.70330868del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1279481" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3114437" TraitType="Disease" MappingType="XRef" MappingValue="C1279481" MappingRef="MedGen">
        <MedGen CUI="C1279481" Name="X-linked severe combined immunodeficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

